{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T09:56:24Z","timestamp":1794736584498,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["No. LQ23H270013"],"award-info":[{"award-number":["No. LQ23H270013"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82204950"],"award-info":[{"award-number":["No. 82204950"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Support Project of Regional Innovation and Development Joint Fund of National Natural Science Foundation of China","award":["No. U23A20499"],"award-info":[{"award-number":["No. U23A20499"]}]},{"name":"Zhejiang Provincial Science and Technology Plan for Traditional Chinese Medicine","award":["2025ZR102"],"award-info":[{"award-number":["2025ZR102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06861-0","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:55:16Z","timestamp":1756814116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["SLC16A3 as an immunosuppressive Kupffer cell marker predicts poor prognosis in HBV-positive hepatocellular carcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingcheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengqi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bochen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanlin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"6861_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"6861_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"6861_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/1055-9965.EPI-24-0686","volume":"33","author":"KA McGlynn","year":"2024","unstructured":"McGlynn KA, Petrick JL, Groopman JD. Liver cancer: progress and priorities. Cancer Epidemiol Biomark Prev. 2024;33:1261\u201372.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"6861_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3:1683\u201391.","journal-title":"JAMA Oncol"},{"key":"6861_CR5","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:S84\u2013101.","journal-title":"J Hepatol"},{"key":"6861_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104992","volume":"159","author":"L Jia","year":"2020","unstructured":"Jia L, Gao Y, He Y, Hooper JD, Yang P. HBV induced hepatocellular carcinoma and related potential immunotherapy. Pharmacol Res. 2020;159: 104992.","journal-title":"Pharmacol Res"},{"key":"6861_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/bj1540405","volume":"154","author":"TL Spencer","year":"1976","unstructured":"Spencer TL, Lehninger AL. L-lactate transport in Ehrlich ascites-tumour cells. Biochem J. 1976;154:405\u201314.","journal-title":"Biochem J"},{"key":"6861_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/liv.12466","volume":"34","author":"A Ohno","year":"2014","unstructured":"Ohno A, Yorita K, Haruyama Y, Kondo K, Kato A, Ohtomo T, Kawaguchi M, Marutuska K, Chijiiwa K, Kataoka H. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma. Liver Int. 2014;34:942\u201352.","journal-title":"Liver Int"},{"key":"6861_CR9","doi-asserted-by":"publisher","first-page":"11780","DOI":"10.3748\/wjg.v20.i33.11780","volume":"20","author":"VA Alves","year":"2014","unstructured":"Alves VA, Pinheiro C, Morais-Santos F, Felipe-Silva A, Longatto-Filho A, Baltazar F. Characterization of monocarboxylate transporter activity in hepatocellular carcinoma. World J Gastroenterol. 2014;20:11780\u20137.","journal-title":"World J Gastroenterol"},{"key":"6861_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102038","volume":"6","author":"K Yasukawa","year":"2025","unstructured":"Yasukawa K, Shimada S, Akiyama Y, Taniai T, Igarashi Y, Tsukihara S, Tanji Y, Umemura K, Kamachi A, Nara A, et al. ACVR2A attenuation impacts lactate production and hyperglycolytic conditions attracting regulatory T cells in hepatocellular carcinoma. Cell Rep Med. 2025;6: 102038.","journal-title":"Cell Rep Med"},{"key":"6861_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70272","volume":"28","author":"Q Kang","year":"2024","unstructured":"Kang Q, Yin X, Wu Z, Zheng A, Feng L, Ma X, Li L. Integrated single-cell and spatial transcriptome reveal metabolic gene SLC16A3 as a key regulator of immune suppression in hepatocellular carcinoma. J Cell Mol Med. 2024;28: e70272.","journal-title":"J Cell Mol Med"},{"key":"6861_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216824","volume":"589","author":"T Yu","year":"2024","unstructured":"Yu T, Liu Z, Tao Q, Xu X, Li X, Li Y, Chen M, Liu R, Chen D, Wu M, Yu J. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming. Cancer Lett. 2024;589: 216824.","journal-title":"Cancer Lett"},{"key":"6861_CR13","doi-asserted-by":"publisher","first-page":"20135","DOI":"10.1074\/jbc.RA119.009093","volume":"294","author":"Y Contreras-Baeza","year":"2019","unstructured":"Contreras-Baeza Y, Sandoval PY, Alarc\u00f3n R, Galaz A, Cort\u00e9s-Molina F, Alegr\u00eda K, Baeza-Lehnert F, Arce-Molina R, Guequ\u00e9n A, Flores CA, et al. Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments. J Biol Chem. 2019;294:20135\u201347.","journal-title":"J Biol Chem"},{"key":"6861_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.641978","volume":"9","author":"A Markou","year":"2021","unstructured":"Markou A, Tzanikou E, Kallergi G, Pantazaka E, Georgoulias V, Kotsakis A, Lianidou E. Evaluation of monocarboxylate transporter 4 (MCT4) expression and its prognostic significance in circulating tumor cells from patients with early stage non-small-cell lung cancer. Front Cell Dev Biol. 2021;9: 641978.","journal-title":"Front Cell Dev Biol"},{"key":"6861_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.704857","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Zhao B, Yan WH, Xia Y, Wang ZH, Zheng GY, Wang WD, Zhang YS. Integrative analysis identified MCT4 as an independent prognostic factor for bladder cancer. Front Oncol. 2021;11: 704857.","journal-title":"Front Oncol"},{"key":"6861_CR16","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1080\/21655979.2021.1951928","volume":"12","author":"C Yuan","year":"2021","unstructured":"Yuan C, Zhang J, Lou J, Wang S, Jiang Y, Wu F, Wang S. Comprehensive Analysis of Monocarboxylate Transporter 4 (MCT4) expression in breast cancer prognosis and immune infiltration via integrated bioinformatics analysis. Bioengineered. 2021;12:3850\u201363.","journal-title":"Bioengineered"},{"key":"6861_CR17","doi-asserted-by":"publisher","first-page":"2649491","DOI":"10.1155\/2018\/2649491","volume":"2018","author":"L He","year":"2018","unstructured":"He L, Wang H, Zhang Y, Geng L, Yang M, Xu Z, Zou K, Xu W, Gong S. Evaluation of monocarboxylate transporter 4 in inflammatory bowel disease and its potential use as a diagnostic marker. Dis Markers. 2018;2018:2649491.","journal-title":"Dis Markers"},{"key":"6861_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.644862","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhou X, Zou K, Chen G, Huang L, Yang F, Pan W, Xu H, Xu Z, Chen H, et al. Monocarboxylate transporter 4 triggered cell pyroptosis to aggravate intestinal inflammation in inflammatory bowel disease. Front Immunol. 2021;12: 644862.","journal-title":"Front Immunol"},{"key":"6861_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12673","volume":"52","author":"S Zhang","year":"2019","unstructured":"Zhang S, Xu W, Wang H, Cao M, Li M, Zhao J, Hu Y, Wang Y, Li S, Xie Y, et al. Inhibition of CREB-mediated ZO-1 and activation of NF-\u03baB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function. Cell Prolif. 2019;52: e12673.","journal-title":"Cell Prolif"},{"key":"6861_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.seminoncol.2014.03.002","volume":"41","author":"U Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn U, Sotgia F, Lisanti MP. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function. Semin Oncol. 2014;41:195\u2013216.","journal-title":"Semin Oncol"},{"key":"6861_CR21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh PR, Raychaudhuri S. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"6861_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, Srivastava A, Molla G, Madad S, Fernandez-Granda C, Satija R. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"6861_CR23","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.","journal-title":"Innovation"},{"key":"6861_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"6861_CR25","doi-asserted-by":"publisher","first-page":"1579126","DOI":"10.3389\/fphar.2025.1579126","volume":"16","author":"C Liu","year":"2025","unstructured":"Liu C, Huang J, Cai P, Jiang M, Chen H. From COPD to cancer: indacaterol\u2019s unexpected role in combating NSCLC. Front Pharmacol. 2025;16:1579126.","journal-title":"Front Pharmacol"},{"key":"6861_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2025.115505","volume":"202","author":"S Li","year":"2025","unstructured":"Li S, Guo Y, Cui X, Li L, Fan J, Cao J. Cr (VI) induces lactate utilization through HIF-1\u03b1\/MCT1 dependent on p53 protein level. Food Chem Toxicol. 2025;202: 115505.","journal-title":"Food Chem Toxicol"},{"key":"6861_CR27","volume":"51","author":"Z Hui","year":"2024","unstructured":"Hui Z, Yu W, Fuzhen W, Liping S, Guomin Z, Jianhua L, Feng W, Ning M, Jian L, Guowei D, et al. New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020. Lancet Reg Health West Pac. 2024;51: 101193.","journal-title":"Lancet Reg Health West Pac"},{"key":"6861_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104511","volume":"150","author":"AF Abdel-Wahab","year":"2019","unstructured":"Abdel-Wahab AF, Mahmoud W, Al-Harizy RM. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res. 2019;150: 104511.","journal-title":"Pharmacol Res"},{"key":"6861_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"6861_CR30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","volume":"34","author":"AP Halestrap","year":"2013","unstructured":"Halestrap AP. The SLC16 gene family\u2014structure, role and regulation in health and disease. Mol Aspects Med. 2013;34:337\u201349.","journal-title":"Mol Aspects Med"},{"key":"6861_CR31","first-page":"1511","volume":"29","author":"F Baltazar","year":"2014","unstructured":"Baltazar F, Pinheiro C, Morais-Santos F, Azevedo-Silva J, Queir\u00f3s O, Preto A, Casal M. Monocarboxylate transporters as targets and mediators in cancer therapy response. Histol Histopathol. 2014;29:1511\u201324.","journal-title":"Histol Histopathol"},{"key":"6861_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4562","volume":"237","author":"F Baenke","year":"2015","unstructured":"Baenke F, Dubuis S, Brault C, Weigelt B, Dankworth B, Griffiths B, Jiang M, Mackay A, Saunders B, Spencer-Dene B, et al. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival. J Pathol. 2015;237:152\u201365.","journal-title":"J Pathol"},{"key":"6861_CR33","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.celrep.2014.11.025","volume":"9","author":"G Baek","year":"2014","unstructured":"Baek G, Tse YF, Hu Z, Cox D, Buboltz N, McCue P, Yeo CJ, White MA, DeBerardinis RJ, Knudsen ES, Witkiewicz AK. MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep. 2014;9:2233\u201349.","journal-title":"Cell Rep"},{"key":"6861_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:126.","journal-title":"J Exp Clin Cancer Res"},{"key":"6861_CR35","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.2147\/IJGM.S353592","volume":"15","author":"Q Tao","year":"2022","unstructured":"Tao Q, Li X, Zhu T, Ge X, Gong S, Guo J, Ma R. Lactate transporter SLC16A3 (MCT4) as an onco-immunological biomarker associating tumor microenvironment and immune responses in lung cancer. Int J Gen Med. 2022;15:4465\u201374.","journal-title":"Int J Gen Med"},{"key":"6861_CR36","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.immuni.2022.07.001","volume":"55","author":"Z Gong","year":"2022","unstructured":"Gong Z, Li Q, Shi J, Wei J, Li P, Chang CH, Shultz LD, Ren G. Lung fibroblasts facilitate pre-metastatic niche formation by remodeling the local immune microenvironment. Immunity. 2022;55:1483-1500.e1489.","journal-title":"Immunity"},{"key":"6861_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41590-019-0559-y","volume":"21","author":"A Jain","year":"2020","unstructured":"Jain A, Irizarry-Caro RA, McDaniel MM, Chawla AS, Carroll KR, Overcast GR, Philip NH, Oberst A, Chervonsky AV, Katz JD, Pasare C. T cells instruct myeloid cells to produce inflammasome-independent IL-1\u03b2 and cause autoimmunity. Nat Immunol. 2020;21:65\u201374.","journal-title":"Nat Immunol"},{"key":"6861_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1574884710666151020100059","volume":"10","author":"NH Bhayani","year":"2015","unstructured":"Bhayani NH, Jiang Y, Hamed O, Kimchi ET, Staveley-O\u2019Carroll KF, Gusani NJ. Advances in the pharmacologic treatment of hepatocellular carcinoma. Curr Clin Pharmacol. 2015;10:299\u2013304.","journal-title":"Curr Clin Pharmacol"},{"key":"6861_CR39","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","volume":"66","author":"L Liu","year":"2006","unstructured":"Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5. Cancer Res. 2006;66:11851\u20138.","journal-title":"Cancer Res"},{"key":"6861_CR40","doi-asserted-by":"publisher","first-page":"9149","DOI":"10.1038\/srep09149","volume":"5","author":"V Tesori","year":"2015","unstructured":"Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, et al. The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing. Sci Rep. 2015;5:9149.","journal-title":"Sci Rep"},{"key":"6861_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25\u201334.","journal-title":"Lancet Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06861-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:26:39Z","timestamp":1756902399000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06861-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6861"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06861-0","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patient specimens were gathered with signed informed consent from the patients, and ethics approval form Henan Ethics Committee (Project No. ZL-XP201402).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"988"}}